[go: up one dir, main page]

DE69419408D1 - Tylosin enthaltende tieraerztliche zubereitungen mit verzoegerter wirkstoffabgabe - Google Patents

Tylosin enthaltende tieraerztliche zubereitungen mit verzoegerter wirkstoffabgabe

Info

Publication number
DE69419408D1
DE69419408D1 DE69419408T DE69419408T DE69419408D1 DE 69419408 D1 DE69419408 D1 DE 69419408D1 DE 69419408 T DE69419408 T DE 69419408T DE 69419408 T DE69419408 T DE 69419408T DE 69419408 D1 DE69419408 D1 DE 69419408D1
Authority
DE
Germany
Prior art keywords
active substance
preparations containing
delayed delivery
veterinary preparations
gelling agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69419408T
Other languages
English (en)
Other versions
DE69419408T2 (de
Inventor
Alan Patterson
Drew Holmes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norbrook Laboratories Ltd
Original Assignee
Norbrook Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Laboratories Ltd filed Critical Norbrook Laboratories Ltd
Publication of DE69419408D1 publication Critical patent/DE69419408D1/de
Application granted granted Critical
Publication of DE69419408T2 publication Critical patent/DE69419408T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE69419408T 1993-03-24 1994-03-22 Tylosin enthaltende tieraerztliche zubereitungen mit verzoegerter wirkstoffabgabe Expired - Lifetime DE69419408T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939306106A GB9306106D0 (en) 1993-03-24 1993-03-24 Sustained release veterinary composition
PCT/GB1994/000578 WO1994021267A1 (en) 1993-03-24 1994-03-22 Tylosin containing sustained release veterinary compositions

Publications (2)

Publication Number Publication Date
DE69419408D1 true DE69419408D1 (de) 1999-08-12
DE69419408T2 DE69419408T2 (de) 1999-10-28

Family

ID=10732660

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69419408T Expired - Lifetime DE69419408T2 (de) 1993-03-24 1994-03-22 Tylosin enthaltende tieraerztliche zubereitungen mit verzoegerter wirkstoffabgabe

Country Status (23)

Country Link
EP (1) EP0689444B1 (de)
JP (1) JPH08508032A (de)
KR (1) KR100283369B1 (de)
CN (1) CN1096268C (de)
AT (1) ATE181834T1 (de)
AU (1) AU669435B2 (de)
BG (1) BG62352B1 (de)
BR (1) BR9406202A (de)
CA (1) CA2158662C (de)
DE (1) DE69419408T2 (de)
DK (1) DK0689444T3 (de)
ES (1) ES2135568T3 (de)
FI (1) FI954447L (de)
GB (1) GB9306106D0 (de)
GR (1) GR3031293T3 (de)
HU (1) HUT73424A (de)
IL (1) IL109053A (de)
NO (1) NO953647L (de)
NZ (1) NZ262756A (de)
PE (1) PE7595A1 (de)
PL (1) PL175127B1 (de)
RO (1) RO114738B1 (de)
WO (1) WO1994021267A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
CN1326526C (zh) * 2002-10-25 2007-07-18 英特威国际有限公司 延长释放的药物组合物
MD4037666T2 (ro) 2020-12-08 2024-09-30 Ruminant Biotech Corp Ltd Îmbunătățiri ale dispozitivelor și metodelor de furnizare a substanțelor la animale
CN116407505A (zh) * 2023-03-28 2023-07-11 青岛康地恩动物药业有限公司 一种高生物利用度泰万菌素干混悬剂及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105589B (en) * 1981-09-11 1985-10-23 Wellcome Found Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent
PT76448B (en) * 1982-04-05 1986-03-20 Merck Sharp & Dohme Process for preparing stabilization of unstable drugs or food supplements containing antibiotics mainly ephrotomycin
US4597969A (en) * 1982-04-05 1986-07-01 Merck Sharp & Dohme Stabilization of unstable drugs or food supplements
ES2024444B3 (es) * 1986-03-10 1992-03-01 American Cyanamid Co Metodo para la preparacion de formulacion de pildoras gruesas de liberacion sostenida.
US4994227A (en) * 1986-03-10 1991-02-19 American Cyanamid Company Method for the preparation of sustained released bolus formulation

Also Published As

Publication number Publication date
CA2158662A1 (en) 1994-09-29
AU669435B2 (en) 1996-06-06
NO953647D0 (no) 1995-09-15
BR9406202A (pt) 1995-12-12
GR3031293T3 (en) 1999-12-31
KR960700732A (ko) 1996-02-24
CN1123525A (zh) 1996-05-29
KR100283369B1 (ko) 2001-03-02
PE7595A1 (es) 1995-04-25
PL310804A1 (en) 1996-01-08
HU9502700D0 (en) 1995-11-28
GB9306106D0 (en) 1993-05-12
IL109053A (en) 1999-09-22
JPH08508032A (ja) 1996-08-27
ATE181834T1 (de) 1999-07-15
NO953647L (no) 1995-11-22
RO114738B1 (ro) 1999-07-30
HUT73424A (en) 1996-07-29
FI954447A0 (fi) 1995-09-20
PL175127B1 (pl) 1998-11-30
ES2135568T3 (es) 1999-11-01
FI954447L (fi) 1995-11-15
DK0689444T3 (da) 1999-11-22
EP0689444A1 (de) 1996-01-03
CN1096268C (zh) 2002-12-18
WO1994021267A1 (en) 1994-09-29
BG62352B1 (bg) 1999-09-30
IL109053A0 (en) 1994-06-24
DE69419408T2 (de) 1999-10-28
NZ262756A (en) 1997-06-24
AU6262194A (en) 1994-10-11
CA2158662C (en) 2009-06-30
BG100078A (bg) 1996-07-31
EP0689444B1 (de) 1999-07-07

Similar Documents

Publication Publication Date Title
ES2529167T3 (es) Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares
AU4275597A (en) Erythropoietin drug delivery system
FI872481A0 (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
AR006308A1 (es) Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador.
CA2063576A1 (en) Slow release vehicles for minimizing skin irritancy of topical compositions
IE940583L (en) Topical antimicrobial pharmaceutical compositions
AU2701792A (en) Slow release syneresing polymeric drug delivery device
PT942724E (pt) Formulacoes em gel para libertacao topica de farmacos
ES2186715T3 (es) Uso de un tensioactivo lipofilico en una composicion farmaceutica.
EP2106787A3 (de) Biologisch abbaubare Blockcopolymer-Zusammensetzungen zur Arzneimittelabgabe
NZ330369A (en) aqueous medicaments containing 9-hydroxy-risperidone fatty acid ester
SI1187601T1 (sl) Novi pripravek in dajalna oblika, ki obsega kislinsko labilen inhibitor protonske crpalke
UA27058C2 (uk) Фармацевтичhа композиція, що призhачеhа для одержаhhя порошків або шипучих таблеток, яка містить ефективhу кількість ібупрофеhу, фармацевтичhий препарат hа її осhові та спосіб його одержаhhя
MY132911A (en) Clear, injectable solution of an anesthetic compound
DE69215770D1 (de) Pelletförmige Zusammensetzung, die Wirkstoffe enthält, die nicht geschützt sind gegen Abbau im Pansen von Wiederkäuern zusammen mit Wirkstoffen, die geschützt sind gegen Abbau im Pansen von Wiederkäuern
DE69419408D1 (de) Tylosin enthaltende tieraerztliche zubereitungen mit verzoegerter wirkstoffabgabe
AU692801B2 (en) Pharmaceutical compositions comprising a staurosporine as active ingredient.
ES2111102T3 (es) Formulaciones cosmeticas y dermatologicas con un contenido activo en acido cis-urocaninico.
TR199902748T2 (xx) Uzun s�re etkili antimikrobik maddelerle ilgili geli�meler
JPS5750914A (en) Betamethasone external pharmaceutical
WO1998033478A3 (en) Rna- and dna-based active agents in nanoparticles
WO2001003774A3 (en) Pharmaceutical composition for the treatment of calcification
RU97113599A (ru) Ранозаживляющая композиция "леста"
TH22810A (th) " สื่อนำส่งแบบไร้น้ำสำหรับส่วนประกอบเครื่องสำอาง "

Legal Events

Date Code Title Description
8364 No opposition during term of opposition